This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Jan 10;100(2):55-56.

doi: 10.1212/WNL.0000000000201366. Epub 2022 Sep 20.

SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the Risk

Jeffrey A Allen¹

Affiliations

PMID: 36127140
DOI: 10.1212/WNL.0000000000201366

Editorial

SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the Risk

Jeffrey A Allen. Neurology. 2023.

. 2023 Jan 10;100(2):55-56.

doi: 10.1212/WNL.0000000000201366. Epub 2022 Sep 20.

Author

Jeffrey A Allen¹

Affiliation

¹ From the University of Minnesota, Minneapolis, MN. jaallen@umn.edu.

PMID: 36127140
DOI: 10.1212/WNL.0000000000201366

No abstract available

PubMed Disclaimer

Comment on

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
Baars AE, Kuitwaard K, de Koning LC, Luijten LWG, Kok WM, Eftimov F, Wieske L, Goedee HS, van der Pol WL, Blomkwist-Markens PH, Horemans AMC, Jacobs BC, van Doorn PA. Baars AE, et al. Neurology. 2023 Jan 10;100(2):e182-e191. doi: 10.1212/WNL.0000000000201376. Epub 2022 Sep 20. Neurology. 2023. PMID: 36127144

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal